Pulmonary contusion induces alveolar type 2 epithelial cell apoptosis: Role of alveolar macrophages and neutrophils

Shock

Volumn 30, Issue 5, 2008, Pages 537-544

  Seitz, Daniel H ^a   Perl, Mario ^a   Mangold, Stefanie ^a   Neddermann, Anne ^a   Braumüller, Sonja T ^a   Zhou, Shaoixa ^a   Bachem, Max G ^a   Huber Lang, Markus S ^a   Knöferl, Markus W ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Alveolar epithelial cells; Apoptosis; Blunt trauma; Caspase 3; Caspase 8; Fas

Indexed keywords

CASPASE 3; CASPASE 8; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 1BETA; LIPOCORTIN 5; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS MACROPHAGE; LUNG CONTUSION; LUNG LAVAGE; MALE; NEUTROPHIL; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; RAT; THORAX BLUNT TRAUMA;

ANIMALS; APOPTOSIS; CASPASES; CONTUSIONS; CYTOKINES; EPITHELIAL CELLS; FAS LIGAND PROTEIN; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTERLEUKIN-1; LUNG INJURY; MACROPHAGES, ALVEOLAR; MALE; NEUTROPHILS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 55949096196     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31816a394b     Document Type: Article

References (56)

1. Shorr RM, Crittenden M, Indeck M, Hartunian SL, Rodriguez A: Blunt thoracic trauma. Analysis of 515 patients. Ann Surg 206(2):200-205, 1987.
2. Pinilla JC: Acute respiratory failure in severe blunt chest trauma. J Trauma 22(3):221-226, 1982.
3. Waydhas C, Nast-Kolb D, Trupka A, Jochum M, Schweiberer L: Die Bedeutung des traumatisch-hämorrhagischen Schocks und der Thoraxverletzung für die Prognose nach Polytrauma. Hefte Unfallheilkunde 215:104-105, 1990.
4. Trupka A: Konsequenzen der Früherkennung für die frühe Beatmungstherapie. In Nast Kolb D, Waydhas C, Schweiberer L, eds.: Hefte zu der Unfallchirurg, Posttraumatisches Multiorganversagen (253). Berlin: Springer: 1996, 11-16.
5. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER: Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 126(2):332-337, 1982.
6. Uhal BD: Cell cycle kinetics in the alveolar epithelium. Am J Physiol 272(6 Pt 1):L1031-L1045, 1997.
7. Phelps DS, Floros J: Localization of pulmonary surfactant proteins using immunohistochemistry and tissue in situ hybridization. Exp Lung Res 17(6):985-995, 1991.
8. Pison U, Max M, Neuendank A, Weissbach S, Pietschmann S: Host defence capacities of pulmonary surfactant: evidence for 'non-surfactant' functions of the surfactant system. Eur J Clin Invest 24(9):586-599, 1994.
9. Wright JR: Host defense functions of pulmonary surfactant. Neonatology 85(4):326-332, 2004.
10. Perl M, Chung CS, Lomas-Neira J, Rachel TM, Biffl WL, Cioffi WG, Ayala A: Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis. Am J Pathol 167(6):1545-1559, 2005.
11. Perl M, Chung CS, Perl U, Lomas-Neira J, de Paepe M, Cioffi WG, Ayala A: Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. Am J Respir Crit Care Med 176(6):591-601, 2007.
12. Rivo J, Zeira E, Galun E, Einav S, Linden J, Matot I: Attenuation of reperfusion lung injury and apoptosis by A2A adenosine receptor activation is associated with modulation of Bcl-2 and BAX expression and activation of extracellular signal-regulated kinases. Shock 27(3):266-273, 2007.
13. Sutherland LM, Edwards YS, Murray AW: Alveolar type II cell apoptosis. Comp Biochem Physiol A Mol Integr Physiol 129(1):267-285, 2001.
14. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Griffin PR, Labelle M, Lazebnik YA: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43, 1995.
15. Bardales RH, Xie SS, Schaefer RF, Hsu SM: Apoptosis is a major pathway responsible for the resolution of type 11 pneumocytes in acute lung injury. Am J Pathol 149(3):845-852, 1996.
16. Uhal BD, Joshi I, Hughes WF, Ramos C, Pardo A, Selman M: Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol 275(6 Pt 1):L1192-L1199, 1998.
17. Martin TR, Nakamura M, Matute-Bello G: The role of apoptosis in acute lung injury. Crit Care Med 31(4 Suppl):184-188, 2003.
18. Matute-Bello G, Martin TR: Science review: apoptosis in acute lung injury. Crit Care 7(5):355-358, 2003.
19. Dobbs LG, Wright JR, Hawgood S, Gonzalez R, Venstrom K, Nellenbogen J: Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alveolar type II cells. Proc Natl Acad Sci U S A 84(4):1010-1014, 1987.
20. Thorley AJ, Ford PA, Giembycz MA, Goldstraw P, Young A, Tetley TD: Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages. J Immunol 178(1):463-473, 2007.
21. Perl M, Gebhard F, Brückner UB, Ayala A, Braumüller S, Büttner C, Kinzl L, Knöferl MW: Pulmonary contusion causes impairment of macrophage and lymphocyte immune functions and increases mortality associated with a subsequent septic challenge. Crit Care Med 33(6):1351-1358, 2005.
22. Haslett C: Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 160(5 Pt 2):S5-S11, 1999.
23. Serrao KL, Fortenberry JD, Owens ML, Harris FL, Brown LA: Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am J Physiol Lung Cell Mol Physiol 280(2):L298-L305, 2001.
24. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL: Mechanisms of pancreatic (beta)-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):97-107, 2005.
25. El BH, Rath G, Morjani H, Schneider C, Petitfrere E, Antonicelli F, Martiny L: Interleukin-1beta-induced apoptosis through adenylyl cyclase and ERK1/2 inhibition in primary cultured thyroid cells. Biochem Biophys Res Commun 339(2):469-476, 2006.
26. Laster SM, Wood JG, Gooding LR: Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol 141(8):2629-2634, 1988.
27. Li Y, Zhang W, Mantell LL, Kazzaz JA, Fein AM, Horowitz S: Nuclear Factor-kappa B Is Activated by Hyperoxia but Does Not Protect from Cell Death. J Biol Chem 272(33):20646-20649, 1997.
28. Irwin RJ, Lerner MR, Bealer JF, Brackett DJ, Tuggle DW: Cardiopulmonary physiology of primary blast injury. J Trauma 43(4):650-655, 1997.
29. Jaffin JH, McKinney L, Kinney RC, Cunningham JA, Moritz DM, Kraimer JM, Graeber GM, Moe JB, Salander JM, Harmon JW: A laboratory model for studying blast overpressure injury. J Trauma 27(4):349-356, 1987.
30. Knöferl MW, Liener UC, Seitz DH, Perl M, Brückner UB, Kinzl L, Gebhard F: Cardiopulmonary, histological, and inflammatory alterations after lung contusion in a novel mouse model of blunt chest trauma. Shock 19(6):519-525, 2003.
31. Liener UC, Knöferl MW, Sträter J, Barth TF, Pauser EM, Nüssler AK, Kinzl L, Brückner UB, Gebhard F: Induction of apoptosis following blunt chest trauma. Shock 20(6):511-516, 2003.
32. Huber-Lang M, Younkin EM, Sarma JV, Riedemann N, McGuire SR, Lu KT, Kunkel R, Younger JG, Zetoune FS, Ward PA: Generation of c5a by phagocytic cells. Am J Pathol 161(5):1849-1859, 2002.
33. Huber-Lang MS, Younkin EM, Sarma JV, McGuire SR, Lu KT, Guo RF, Padgaonkar VA, Curnutte JT, Erickson R, Ward PA: Complement-induced impairment of innate immunity during sepsis. J Immunol 169(6):3223-3231, 2002.
34. Fehrenbach H, Kasper M, Koslowski R, Pan T, Schuh D, Muller M, Mason RJ: Alveolar epithelial type II cell apoptosis in vivo during resolution of keratinocyte growth factor-induced hyperplasia in the rat. Histochem Cell Biol 114(1):49-61, 2000.
35. Dobbs LG: Isolation and culture of alveolar type II cells. Am J Physiol 258 (4 Pt 1):L134-L147, 1990.
36. Dobbs LG, Gonzalez R, Williams MC: An improved method for isolating type II cells in high yield and purity. Am Rev Respir Dis 134(1):141-145, 1986.
37. Haley PJ, Muggenburg BA, Weissman DN, Bice DE: Comparative morphology and morphometry of alveolar macrophages from six species. Am J Anat 191(4):401-407, 1991.
38. Peter ME, Krammer PH: Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 10(5):545-551, 1998.
39. Albertine KH, Soulier MF, Wang Z, Ishizaka A, Hashimoto S, Zimmerman GA, Matthay MA, Ware LB: Fas and Fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol 161(5):1783-1796, 2002.
40. Wang HC, Shun CT, Hsu SM, Kuo SH, Luh KT, Yang PC: Fas/Fas ligand pathway is involved in the resolution of type II pneumocyte hyperplasia after acute lung injury: evidence from a rat model. Crit Care Med 30(7):1528-1534, 2002.
41. Matute-Bello G, Liles WC, Steinberg KP, Kiener PA, Mongovin S, Chi EY, Jonas M, Martin TR: Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 163(4):2217-2225, 1999.
42. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC: Immunohistochemical determination of in vivo distribution of BAX, a dominant inhibitor of Bcl-2. Am J Pathol 145(6):1323-1336, 1994.
43. Guinee D Jr, Brambilla E, Fleming M, Hayashi T, Rahn M, Koss M, Ferrans V, Travis W: The potential role of BAX and BCL-2 expression in diffuse alveolar damage. Am J Pathol 151(4):999-1007, 1997.
44. Zhao J, Schmid-Kotsas A, Gross HJ, Gruenert A, Bachem MG: Sensitivity and specificity of different staining methods to monitor apoptosis induced by oxidative stress in adherent cells. Chin Med J (Engl) 116(12):1923-1929, 2003.
45. Vermes I, Haanen C, Steffens-Nakken H, Reutellingsperger C: A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 184(1):39-51, 1995.
46. Gorbunov NV, Elsayed NM, Kisin ER, Kozlov AV, Kagan VE: Air blast-induced pulmonary oxidative stress: interplay among hemoglobin, antioxidants, and lipid peroxidation. Am J Physiol 272(2 Pt 1):L320-L334, 1997.
47. Janssen YM, Soultanakis R, Steece K, Heerdt E, Singh RJ, Joseph J, Kalyanaraman B: Depletion of nitric oxide causes cell cycle alterations, apoptosis, and oxidative stress in pulmonary cells. Am J Physiol 275(6 Pt 1):L1100-L1109, 1998.
48. Wang L, Medan D, Mercer R, Overmiller D, Leornard S, Castranova V, Shi X, Ding M, Huang C, Rojanasakul Y: Vanadium-induced apoptosis and pulmonary inflammation in mice: role of reactive oxygen species. J Cell Physiol 195(1):99-107, 2003.
49. Brown LA, Harris FL, Jones DP: Ascorbate deficiency and oxidative stress in the alveolar type II cell. Am J Physiol 273(4 Pt 1):L782-L788, 1997.
50. Rignault S, Haefliger JA, Waeber B, Liaudet L, Feihl F: Acute inflammation decreases the expression of connexin 40 in mouse lung. Shock 28(1):78-85, 2007.
51. Lin SM, Lin HC, Lee KY, Huang CD, Liu CY, Wang CH, Kuo HP: Ventilator-induced injury augments interleukin-1beta production and neutrophil sequestration in lipopolysaccharide-treated lungs. Shock 28(4):453-460, 2007.
52. Hybertson BM, Lee YM, Cho HG, Cho OJ, Repine JE: Alveolar type II cell abnormalities and peroxide formation in lungs of rats given IL-1 intratracheally. Inflammation 24(4):289-303, 2000.
53. Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D: A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 264(20):11974-11980, 1989.
54. Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP: Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 266(16):10331-10336, 1991.
55. Park WY, Goodman RB, Steinberg KP, Rudzinski JT, Radella FI, Park DR, Pugin J, Skerrett SJ, Hudson LD, Martin TR: Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 164(10):1896-1903, 2001.
56. Mikuniya T, Nagai S, Takeuchi M, Mio T, Hoshino Y, Miki H, Shigematsu M, Hamada K, Izumi T: Significance of the interleukin-1 receptor antagonist/interleukin-1b ratio as a prognostic factor in patients with pulmonary sarcoidosis. Respiration 67(4):389-396, 2000.